Porcine reproductive and respiratory syndrome virus antigen and processes for the preparation and use of said antigen in vaccines and diagnostics
AssigneesBayer Aktiengesellschaft, Iowa State University Research Foundation, Inc.
InventorsThomas Sanderson, Michael J. McGinley, Jeffrey J. Zimmerman, Howard T. Hill, Michael C. Meetz, Eugene C. Pirtle, Sabrina L. Swenson, George P. Shibley
Life of this patent
Estimating the term…
Abstract
A process for growing a PRRSV in a tissue culture which is susceptible to infection to replicate the virus to an amount sufficient to protect animals against PRRS or be used in diagnosing PRRS or identifying the molecular structure of PRRSV for development of recombinant products, comprising inoculating the virus onto the tissue culture and harvesting the replicated virus.
Claims3
A vaccine prepared by the process of growing a porcine reproductive and respiratory syndrome virus (PRRSV) in a tissue which is susceptible to infection and replication of PRRSV to an amount sufficient to protect animals against PRRS comprising inoculating the PRRSV onto tissue cells and harvesting the replicated virus, releasing the virus from the tissue cells and adjusting the virus antigenic mass by dilution, concentration or extraction to produce an immunologically effective amount of the antigenic mass for a modified live or inactivated formulation of the vaccine wherein the PRRSV is an isolate designated as ISU-P and having an Accession number ATCC VR 2402.
A porcine reproductive and respiratory syndrome virus isolate designated as ISU-P and having an Accession number ATCC VR 2402.
A continuous cell line designated as 9009B and having an Accession Number ATCC CRL 11302.
Dependencies are inferred from the claim text.